Artiva Biotherapeutics (ARTV) Shares Outstanding (2023 - 2026)

Artiva Biotherapeutics (ARTV) has 4 years of Shares Outstanding data on file, last reported at $24.7 million in Q1 2026.

• Shares Outstanding for Q1 2026 came in at $24.7 million, up 1.45% year-over-year; the trailing twelve-month figure through Mar 2026 was $24.7 million (up 1.45% YoY), and the FY2025 annual result was $24.6 million, up 1.25% from the prior year.
• Shares Outstanding steadied at $24.7 million in Q1 2026 per ARTV's latest filing, from $24.6 million in the prior quarter.
• Over five years, Shares Outstanding peaked at $24.7 million in Q1 2026 and troughed at $805199.0 in Q2 2023.
• A 4-year average of $14.8 million and a median of $24.3 million in 2024 frame the typical range for Shares Outstanding.
• On a YoY basis, Shares Outstanding climbed as much as 2908.69% in 2025 and fell as far as 1.06% in 2025.
• A 4-year view of Shares Outstanding shows it stood at $809758.0 in 2023, then surged by 2899.86% to $24.3 million in 2024, then increased by 1.25% to $24.6 million in 2025, then advanced by 0.49% to $24.7 million in 2026.
• Business Quant data shows ARTV's Shares Outstanding at $24.7 million in Q1 2026, $24.6 million in Q4 2025, and $24.5 million in Q3 2025.